The MMR germline carriers with endometrial cancer had more somatic MMR variants, while those with ovarian cancer harbored more common variants in driver genes, including KRAS, ARID1A, and PTEN (Figure 3A). This evidence concerns the gene ARID1A and ovarian carcinoma.